학술논문
Phase I Dose-Escalation Study of JNJ-42756493, an Oral Pan-Fibroblast Growth Factor Receptor Inhibitor, in Patients With Advanced Solid Tumors.
Document Type
journal article
Author
Tabernero, Josep; Bahleda, Rastislav; Dienstmann, Rodrigo; Infante, Jeffrey R.; Mita, Alain; Italiano, Antoine; Calvo, Emiliano; Moreno, Victor; Adamo, Barbara; Gazzah, Anas; Zhong, Bob; Platero, Suso J.; Smit, Johan W.; Stuyckens, Kim; Chatterjee-Kishore, Moitreyee; Rodon, Jordi; Peddareddigari, Vijay; Luo, Feng R.; Soria, Jean-Charles
Source
Journal of Clinical Oncology; 10/20/2015, Vol. 33 Issue 30, p3401-3408, 8p
Subject
Language
ISSN
0732183X